Open Insider Trading Activity for Trillium Therapeutics Inc. Chief Scientific Officer Uger Robert
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-07-09 | 2021-07-07 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 3,646 | $9.00 | $32,814.00 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-06-09 | 2021-06-07 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 3,646 | $8.27 | $30,152.42 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-05-11 | 2021-05-07 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 3,646 | $9.30 | $33,907.80 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-03-10 | 2021-03-08 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 3,646 | $10.11 | $36,861.06 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-02-10 | 2021-02-09 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 2 | 7,147 | $12.77 | $91,268.03 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-01-13 | 2021-01-11 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 584 | $15.20 | $8,876.80 | 100.00% | View Filing |
| Explained M/S: sale activity tied to share conversions or derivative-related share movements. TRIL | 2021-01-11 | 2021-01-07 | Trillium Therapeutics Inc. | Uger Robert | Chief Scientific Officer | Sell | 1 | 3,646 | $14.75 | $53,778.50 | 100.00% | View Filing |